Webcast | China Valve (HangZhou)
2018-03-30 12:00:00 ～ 2018-04-01 12:00:00
Webcast Introduction
Incidence of valvular heart diseases keeps increasing along with the aging trend of the world. As the evidence accumulates, transcatheter valvular replacement or repair emerged as an alternative for traditional cardiac surgery, especially in the field of transcatheter aortic valve replacement (TAVR). To improve transcatheter valvular treatment in China and international collaboration in the field, the fourthChina Valve (Hangzhou) congress will be held on 30th March to 1st April 2018. This year, we will continuously work with the support of CSI to provide a broader global vision, an improved training course and a deeper communicative platform.
Program
Echo Training Workshop
08:30-11:10 Pearl 1
Chairpersons:Xiang-Dong YOU, Wei-Hsian YIN, Mao CHEN, Zhao-Xia PU, Cui-Zhen PAN, Hong TANG, Hao WANG , Ping YANG
Time
Speaker
Title
Comments
08:30-08:50
Xiang-Dong YOU
Updated guidelines for recommendations on the echocardiographic assessment of aortic valve stenosis
08:50-09:10
Hong TANG
Standardized Defnition of Structural Valve Degeneration for transcatheter bioprosthetic aortic valves: echocardiographic criteria
09:10-09:30
Hao WANG
Dobutamine test for patients with Stage D2 AS
09:30-09:50
Cui-Zhen PAN
TTE or TEE selection during TAVR: Pros and Cons
09:50-10:10
Lei YU
Long-term echocardiographic follow-up results from latest clinical trials
10:10-10:20
Zhao-Xia PU
How to perform perfect echocardiographic images for aortic valve disease
10:30-10:50
Zhao-Xu HUANG
Case report: a typical AS patient undergoing TAVR
10:50-11:10
Li-Ming ZHOU
Case report: a patient with contraindication for TAVR
11:10-11:30
讨论
Anesthesia Training Workshop
08:30-11:20 Pearl 2
Chairpersons:Min YAN, Yong-Jian WU, Da-Xin ZHOU, Ming-Zheng LIU, Guo CHEN, Ke-Fang GUO, Xian-He LIN , Guo-Qing LI
Time
Speaker
Title
Comments
08:30-08:50
Min YAN
Preprocedural TAVR anesthesia evaluation and anesthetic strategy
08:50-09:10
Guo CHEN
Preprocedural TAVR anesthesia preparation and anesthesia medication choice
09:10-09:30
Yong XU
Airway management in TAVR
09:50-10:10
Ming-Zheng LIU
Conversion to surgery: role of anesthesiologist and typical cases
10:10-10:30
Ke-Fang GUO
Post-TAVR anesthesia recovery
09:30-09:50
Wei HE
讨论
10:30-11:00
Debate (10min Presentation & 5 min Discussion)
Jian-An WANG
I prefer LA
Yat-Yin LAM
I prefer GA
11:00-11:20
All
Experience sharing from TAVR centers in China
CT Training Workshop
08:30-11:30
Chairpersons:Guang-Yuan SONG, Wen-Zhi PAN, Xiang MA, Long-Yan ZHANG, Wei MA, Shen-Wei ZHANG
Time
Speaker
Title
Comments
08:30-08:50
Qi-Jing ZHOU
CT scanning mode and parameters for TAVR
08:50-09:10
Yuan FENG
Assessment of vascular accesses
09:10-09:30
Xian-Bao LIU
Classifcation of aortic valve type
09:30-09:50
Jie LI
Evaluation of calcifcation of aortic root
09:50-10:10
Mo-Yang WANG
Valve-in-valve assessment
10:10-10:30
Yu-Xin HE
Other fndings from pre-TAVR CT screening
10:30-10:50
Wen-Zhi PAN
post-TAVR CT follow-up
10:50-11:10
Qi-Feng ZHU
Live demonstration: 3mensio
11:10-11:30
Guang-Yuan SONG
Live demonstration: Circle
Session 1 Learn from TAVR recorded case step by step
13:00-14:20 Crystal Ballroom
Chairpersons:Yu-Jie ZHOU, Ben HE, Hong-Ju WANG, Zai-Xin YU, Shi-Hua ZHAO, Ding-Li XU, Kai HUANG , Mei-Xiang XIANG
Time
Speaker
Title
Comments
13:00-13:08
Xian-Bao LIU
Case introduction
13:08-13:16
Lei YU
Echocardiographic assessment
13:16-13:24
Yu-Xin HE
CT assessment
13:24-13:32
Jian-An WANG, Ai-Qiang DONG, Xian-Bao LIU, Wei HE, Lei YU, Qi-Jing ZHOU, Ji-Fang CHENG, Yu-Xin HE
Heart team discussion(cardiologist, surgeon, echocardiographer, anesthesiologist, radiologist, nurse)
13:32-14:00
Jian-An WANG
Recorded TAVR case step by step
14:00-14:20
Discussion
14:20-14:30
Cofee Break
Session 2 Learn from masters—Access
14:30-16:10 Crystal Ballroom
Chairpersons: Wei-Hsian YIN, Mao CHEN, Wei-Yi FANG, Nai-Feng LIU, Feng BAI, Liang-Long CHEN , He-Song ZENG, Yong SUN
Time
Speaker
Title
Comments
14:30-14:35
Wei-Hsian YIN
Learning Objectives
14:35-14:50
Mao CHEN
Assessment of femoral artery and tips for puncture
14:50-15:05
Atiq REHMAN
TAVR in patients with borderline femoral artery
15:05-15:20
Edgar TAY
Selection and manipulation of vascular closure devices in TF-TAVR
15:20-15:35
Jian-An WANG
Preprocedural evaluation of TF-TAVR beyond femoral artery
15:35-15:50
Da-Xin ZHOU
Trans-carotid TAVR
15:50-16:05
Wei-Hsian YIN
Strategies for selection of vascular accesses and management of complications in TAVR
16:10-16:20
Cofee Break
Session 3 Learn from masters—PVL Treatment
16:20-18:00 Crystal Ballroom
Chairpersons:Horst SIEVERT, Jeng WEI, Rui-Yan ZHANG, Ju-Ying QIAN, Ling TAO, Xian-Xian ZHAO , Robert GOOLEY
Time
Speaker
Title
Comments
16:20-16:25
Horst SIEVERT
Learning Objectives
16:25-16:40
Yong-Jian WU
PVL: incidence, morphology and prognosis
16:55-17:10
Evald Høj CHRISTIANSEN
Assessment of PVL
17:10-17:25
Duk-Woo PARK
Predictive role of CT in PVL
17:40-17:55
Horst SIEVERT
Strategies for the treatment of PVL
17:25-17:40
Yat-Yin LAM
Preventive strategy of PVL
Educational TAVR cases
16:00-18:00
Chairpersons:Edgar TAY, Guang-Yuan SONG, Wen-Zhi PAN, Yan-Qing WU, Bin WANG (Fujian), Zheng-Bin ZHU
Time
Speaker
Title
Comments
16:00-16:12
Jian AN
TAVR for a patient with difcult access
16:12-16:24
Zhi-Gang HAN
TAVR for a patient with difcult access
16:24-16:36
Shen-Wei ZHANG
TAVR for a patient with no calcifed and thickened tricuspid aortic valve
16:36-16:48
Edgar TAY
Balloon expandable valve in a small aortic root complex
16:48-17:00
Ke HAN
TAVR for a patient with mild calcifcation
17:00-17:12
Lian WANG
AS with CAD and bradycardia
17:12-17:24
Jian YANG
TAVR for a patient with horizontal aorta
17:24-17:36
Long-Yan ZHANG
Post TAVR aortic dissection
17:36-17:48
Qi-Feng ZHU
A case report of supra-annular based sizing strategy in TAVR for bicuspid AS
17:48-18:00
Zheng ZHOU
Recurrence of dyspnea post TAVR
18:00-18:12
魏家富
Lotus瓣膜TAVR 1例
Session 4 Learn from TAVR live case step by step
08:00-09:30 Crystal Ballroom
Chairpersons:Jun-Bo GE, Yong-Jian WU, Duk-Woo PARK, Atiq REHMAN, Shah Hinan AHMED, Dong-Ming HOU , Yat-Yin LAM, Sameer GAFOOR, Edgar TAY
Time
Speaker
Title
Comments
08:00-09:30
Jian-An WANG, Xian-Bao LIU
Learn from TAVR live case step by step
Opening Ceremony
09:30-10:00 Crystal Ballroom
Time
Speaker
Title
Comments
09:30-10:00
开幕式
Session 5 Keynote Speeches
10:00-12:00 Crystal Ballroom
Chairpersons:Yong HUO, Jeng WEI, Bo XU, Hasan JILAIHAWI, Yong-Jian WU, Yu-Jie ZHOU, Yi-Tong MA , Chuan-Yu GAO
Time
Speaker
Title
Comments
10:00-10:20
Jun-Bo GE
Opportunities and challenges of TAVR in 2018
10:20-10:40
Xin-Li SHI
Opportunities and challenges of innovations for cardiovascular devices in China
10:40-11:00
Susheel KODALI
Update of 2017 AHA/ACC and EACTS/ESC valvular heart diseaseguidelines for management of patients with
11:00-11:20
Eberhard GRUBE
The future of Minimalist TAVR: inspiration from 3M-TAVR trial
11:20-11:40
Horst SIEVERT
Latest evidences of antiplatelet or anticoagulant strategies in TAVR
11:40-12:00
Jian-An WANG
2017 ACC Expert consensus decision pathway for TAVR
Session 6 Innovation Forum: 15 years of TAVR – where we go from here in Structural Heart?
12:10-13:20 Crystal Ballroom
Chairpersons: Jun-Bo GE, Yong HUO, Jian-An WANG, Horst SIEVERT, Yuval BINUR, Susheel KODALI , Yue-Jin YANG, Ju-Ying QIAN
Time
Speaker
Title
Comments
12:10-12:20
Yuval BINUR
Innovation in China - challenges and opportunities
12:20-12:30
Horst SIEVERT
TAVR open problems and challenges
12:30-12:40
Sameer GAFOOR
The state of mitral repair and replacement
12:40-12:50
Yuval BINUR
Tricuspid, no longer the forgotten Valve
12:50-13:20
Panel with Chinese physicians: Structural Heart in China – are we getting the best products?
Session 7 TAVR clinical studies in China: design and publication
13:30-14:30 Crystal Ballroom
Chairpersons: Bo Xu, Shah Hinan AHMED, Dong-Ming HOU, Sheng-Hua ZHOU, Zu-Yi YUAN, Mei-Lin LIU, Pei-Li BU
Time
Speaker
Title
Comments
13:30-13:50
Dong-Ming HOU
TAVR clinical trial program: tips for design and implementation
13:50-14:10
Shah Hinan AHMED
Translating your research into a high-quality, peer-reviewed publication
14:10-14:30
Discussion
Session 8 TAVR for bicuspid AS and live cases
14:30-17:00 Crystal Ballroom
Chairpersons:Jun-Bo GE, Eberhard GRUBE, Ji-Yan CHEN, Yan WANG, Yi-Gang LI, Da-Xin ZHOU, Xiang-Bin PAN, Evald Høj CHRISTIANSEN, Robert GOOLEY
Time
Speaker
Title
Comments
14:35-15:15
Horst SIEVERT, Xian-Bao LIU
TAVR live case for bicuspid AS with VenusA plus
15:15-15:30
Atiq REHMAN
Evidences of TAVR for patients with bicuspid AS
15:30-16:00
Debate：
Yue-Jin YANG
TAVR in lower risk patients with bicuspid AS – I prefer TAVR
Jeng WEI
TAVR in lower risk patients with bicuspid AS – I prefer SAVR
16:00-16:15
Jian-An WANG
Supra-annular based sizing strategy: Hangzhou experience
16:15-16:55
Wei-Hsian YIN
TAVR live case for bicuspid AS with Sapien3
17:00-17:10
Cofee Break
Session 9 TAVR in special populations
17:10-18:35 Crystal Ballroom
Chairpersons:Susheel KODALI, Xiang-Qing KONG, Ai-Jie HOU, Jian-Fang LUO, Tian-Lun YANG, Atiq REHMAN, Prashant VAIJYANATH, Guang-Yuan SONG
Time
Speaker
Title
Comments
17:15-17:30
Susheel KODALI
Low fow, low gradient and low LVEF severe aortic stenosis
17:30-17:45
Evald Høj CHRISTIANSEN
Non-calcifed severe aortic stenosis
17:45-18:00
Melissa FUSARI
Valve-in-valve
18:00-18:15
Sameer GAFOOR
TAVR for patients with asymptomatic severe AS (Stage C)
18:15-18:30
Ying-Qiang GUO
Pure aortic regurgitation
Challenging TAVR cases
16:00-18:12
Chairpersons:Da-Xin ZHOU, Yat-Yin LAM, Rui-Yan ZHANG, Yuan FENG, Gen-Shan MA, Zhen-Fei FANG, Wei LIU
Time
Speaker
Title
Comments
16:00-16:12
Yi LI
Emergency TAVR with cardiogenic shock
16:12-16:24
Evald Høj CHRISTIANSEN
Fracturing the ring of a small Mitrofow bioprosthesis by high-pressure balloon predilatation in transcatheter aortic valve-in-valve implantation with high risk of left main coronary artery occlusion
16:24-16:36
Bin WANG (Liaoning)
Slippage of super-stif wire from left ventricle after balloon valvuloplasty
16:36-16:48
Da ZHU
J-Valve for bicuspid aortic regurgitation
16:48-17:00
Guan-Nan NIU
Trans-carotid TAVR for a patient with asymmetrical type 0 bicuspid AS
17:00-17:12
Xiao-Ke SHANG
Challenging TAVR cases: TA or TF?
17:12-17:24
Fang-Lin LU
TAVR for a patient with non-calcifed AS
17:24-17:36
Fei LI
A young patient with non-calcifed AS: SAVR or TAVR?
17:36-17:48
Jie LI
TAVR for a patient with severe calcifed bicuspid AS
17:48-18:00
Ren-Qiang YANG
TAVR for a patient with super horizontal aorta
18:00-18:12
Yu-Xin HE
TAVR for a patient with horizontal bicuspid aorta
Session 10 Learn from masters—coronary issues
08:00-09:30 Crystal Ballroom
Chairpersons:Jian-An WANG, Xiang-Hua FU, Da-Xin ZHOU, Yuan FENG, Prashant VAIJYANATH, Yi-Qiang YUAN
Time
Speaker
Title
Comments
08:05-08:20
Xian-Bao LIU
Preprocedural CT evaluation of TAVR for coronary obstruction risk
08:20-08:35
Jian-An WANG
Preventive strategies for coronary obstruction
08:35-08:50
Yan WANG
Management of acute coronary obstruction in TAVR
08:50-09:05
Duk-Woo PARK
Experiences of percutaneous coronary interventions post-TAVR
09:05-09:20
Jian-Fang LUO
Strategies for AS with concomitant coronary artery disease
09:20-09:30
Jian-An WANG
Take Home Message
09:30-09:40
Cofee Break
Session 11 Learn from masters—TAVR high risk patients
09:40-11:10 Crystal Ballroom
Chairpersons:Eberhard GRUBE, Yue-Jin YANG, Ying-Xian SUN, Biao XU, Hasan JILAIHAWI, Ying-Qiang GUO, Jun JIANG, Wen-Zhi PAN
Time
Speaker
Title
Comments
09:45-10:00
Jun-Bo GE
TAVR in patients with very low LVEF
10:00-10:15
Jian-An WANG
TAVR in patients with severe respiratory comorbidities
10:15-10:30
Robert GOOLEY
TAVR in patients with unstable hemodynamics
10:30-10:45
Eberhard GRUBE
TAVR in severe frail patients
10:45-11:00
Atiq REHMAN
TAVR in patients with immunocompromise
11:00-11:10
Eberhard GRUBE
Take Home Message
11:10-11:20
Cofee Break
Session 12 Innovation Forum: New Devices
11:20-12:20 Crystal Ballroom
Chairpersons: Jun-Bo GE, Jian-An WANG, Yuval BINUR, Xin-Chun YANG, Shao-Bin JIA, Ya-Wei XU, Jin-Yu HUANG
Time
Speaker
Title
Comments
11:20-11:26
Jun-Bo GE
Clinical application of VitaFlow transcatheter aortic valve and delivery system
11:26-11:32
Jian-An WANG
VenusA Plus transcatheter aortic valve and delivery system: from R & D to clinical application
11:32-11:38
Mao CHEN
Application of TAV8 balloon for bicuspid AS in TAVR
11:38-11:44
Yong-Jian WU
TaurusOne Transcatheter Aortic Valve
11:44-11:50
Ying-Qiang GUO
J-Valve Transcatheter Aortic Valve
11:56-12:02
Melissa FUSARI
Edwards TAVR innovation and clinical data update
12:02-12:08
Dong-Ming HOU
ACURATE Neo TF for Transcatheter Aortic Valve Replacement
12:08-12:14
Robert GOOLEY
Update of mechanical transcatheter Lotus Edge aortic valve
12:14-12:20
Yuval BINUR
A completely retrievable Direct Flow transcatheter aortic valve
12:20
Jun-Bo GE, Jian-An WANG
Closing remarks
Challenging TAVR cases
10:00-12:00
Chairpersons:Xiang-Qing KONG, Ben HE, Yuan FENG, Melissa FUSARI, Xian-Bao LIU, Xiao-Ke SHANG, Chang-Fu LIU
Time
Speaker
Title
Comments
10:00-10:15
Bin WANG(Fujian)
Acute left main occlusion in TAVR
10:15-10:30
Duk-Woo PARK
Underexpanded self-expandable transcatheter aortic valve prosthesis in calcifed bicuspid aortic valve stenosis: importance of post noncompliant balloon dilatation
10:30-10:45
Li-Han WANG
Extremely high risk TAVR: a case report
10:45-11:00
Yuan FENG
Circulation collapse in TAVR
11:15-11:30
Zhen-Fei FANG
Valve embolism led to aortic dissection in TAVR
11:00-11:15
Feng GAO
Circulation collapse in TAVR
11:30-11:45
Hai-Bo ZHANG
Valve ectopic deployment resulted in renal artery occlusion in TAVR
11:45-12:00
Wen-Zhi PAN
Valve embolism post TAVR